Moderate use averts failure of type 2 diabetes drugs in animal model

Drugs widely used to treat type 2 diabetes may be more likely to keep working if they are used in moderation, researchers at the School of Medicine have found in a study using an animal model. The drugs, sulfonylureas, help type 2 diabetics make more insulin, improving control of blood sugar levels. But in most patients the effects of sulfonylureas are lost after several years of use, causing insulin secretion to shut down.

Deprived of a sense of smell, worms live longer

Video capture by James Collins*C. elegans* roundwormMany animals live longer when raised on low calorie diets. But now researchers at the School of Medicine have shown that they can extend the life spans of roundworms even when the worms are well fed — it just takes a chemical that blocks their sense of smell.

Scientists find new genes linked to lung cancer

Working as part of a multi-institutional collaboration, scientists at the School of Medicine have assembled the most complete catalog to date of the genetic changes underlying the most common form of lung cancer. The research, published Oct. 23 in Nature, helps lay the foundation for more personalized diagnosis and treatment of a disease that is the leading cause of U.S. cancer deaths.

Seemingly suicidal stunt is normal rite of passage for immune cells

Researchers have shown that self-induced breaks in the DNA of immune cells known as lymphocytes activate genes that cause the cells to travel from where they’re made to where they help the body fight invaders. The new finding is the first to link such serious damage to activation of genes not directly involved in the cells’ attempts to either fix the harm or self-destruct to stop themselves from becoming cancerous.

Gordon, Holtzman elected to Institute of Medicine

Two faculty members at the School of Medicine have been elected to the Institute of Medicine of the National Academy of Sciences, one of the highest honors medical scientists in the United States can receive. Jeffrey Gordon and David Holtzman were recognized for their major contributions to the advancement of the medical sciences, health care and public health and commitment to service.

Cause of vision loss in macular degeneration also plays role in diabetic retinopathy, other retinal diseases

Scientists at the School of Medicine have determined that the same factors play key roles in three different diseases that can lead to blindness. In age-related macular degeneration, diabetic retinopathy and retinopathy of prematurity, abnormal blood-vessel growth threatens vision. Reporting in the journal PLoS One, Washington University vision scientists say that although the mechanisms are a bit different, all three retinal diseases involve the same immune-system factors.
Older Stories